Welcome to our dedicated page for Ametek news (Ticker: AME), a resource for investors and traders seeking the latest updates and insights on Ametek stock.
AMETEK, Inc. reports developments as a global industrial technology company serving niche markets through Electronic Instruments and Electromechanical operations. Its news commonly covers operating results, segment trends, dividend actions, board governance and strategic acquisitions tied to analytical, test and measurement instruments, highly engineered components, interconnects, specialty metals and medical technology products.
Company updates also describe AMETEK's capital deployment approach, including acquisitions that expand product portfolios such as ophthalmic diagnostic devices, and recurring financial commentary on sales, margins, cash generation and earnings guidance.
AMETEK reported Q2 2020 financial results with sales of $1.01 billion, a decline of 22% compared to Q2 2019. Operating income was $227 million with margins at 22.4%. GAAP earnings per diluted share were $0.72, while adjusted earnings were $0.84, factoring in intangible amortization. Cash flow from operations rose 28% to $315 million. The Electronic Instruments Group (EIG) saw sales drop to $647.9 million (down 21%), while the Electromechanical Group (EMG) had sales at $364 million (down 22%). No forward guidance was provided due to COVID-19 uncertainties.
AMETEK, Inc. (NYSE: AME) will release its second quarter 2020 earnings report before the market opens on August 4, 2020. The company will host a webcast of the investor conference call on the same day, starting at 8:30 AM ET, accessible via their website. AMETEK, a global leader in electronic instruments and electromechanical devices, reported sales of approximately $5.0 billion in 2019. The firm emphasizes a growth strategy focusing on operational excellence, innovation, market expansion, and strategic acquisitions, aiming for double-digit percentage growth in earnings per share.